Toronto, ON. (March 18, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP and GMP.PR.B) announced that
it has re-filed its audited financial statements and accompanying management’s discussion and analysis
for the year ended December 31, 2010 to correct a calculation error relating to earnings per common
share for 2009.
Toronto, ON. (March 9, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP and GMP.PR.B) announced today
that its board of directors has declared a quarterly cash dividend of $0.1394 per Cumulative 5-Year
Rate Reset Preferred Shares, Series B payable on March 31, 2011 to shareholders of record at the close
of business on March 18, 2011.
For further information about GMP Capital Inc., our results for fiscal 2010 and the meaning of certain references, this press release should be read in conjunction with our 2010 Annual Financial Statements and accompanying Management’s Discussion and Analysis for the year ended December 31, 2010, and our 2010 Annual Information Form, which can be accessed on our website at gmpcapital.com and on SEDAR at sedar.com.
Toronto, ON. (March 2, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP) today reported revenue of $148.4 million in
fourth quarter 2010, representing a 39% increase compared with the same period a year ago due to stronger
revenue performance across all business segments, led by record quarterly revenues in the Capital Markets
segment. Net income was $38.0 million ($0.54 per basic share) compared with net income of $19.5 million in fourth
quarter 2009 ($0.28 per basic share), generating a return on shareholders’ equity (“ROE”)1 of 48.0% in fourth quarter
2010. On March 1, 2011, the Board of Directors approved a 33% increase in the quarterly cash dividend from $0.06
to $0.08 per common share, representing payment for the fourth quarter ended December 31, 2010.
Toronto, ON. (March 1, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP) announced today that it has
closed the over-allotment option granted to the underwriters in connection with GMP’s bought deal
public offering of Cumulative 5-Year Rate Reset Preferred Shares, Series B (the “Series B Shares”),
which closed on February 22, 2011. As a result of the exercise of the over-allotment option, GMP sold
an additional 600,000 Series B Shares at a price of $25.00 per share for additional gross proceeds of
$15,000,000. In total, GMP has issued 4,600,000 Series B Shares for aggregate gross proceeds of
$115,000,000. The Series B Shares trade on the Toronto Stock Exchange under the trading symbol